Intelligent Bio Solutions

Intelligent Bio Solutions Goodwill/Assets

Goodwill to Total Assets Ratio of Intelligent Bio Solutions (INBS) as of Oct 17, 2026.

Goodwill/Assets

-

Last updated:

Goodwill to Total Assets Ratio of Intelligent Bio Solutions is 2026 - . Goodwill to Total Assets Ratio of Intelligent Bio Solutions was 2025 0.00 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions Inc, headquartered in New York City, operates in the Health Care sector as a biosensor diagnostic technology company. The firm develops non-invasive, real-time monitoring and diagnostic tests, focusing on portable drug screening systems and a saliva glucose biosensor platform. It employs 51 full-time staff and went public on 23 December 2020, operating through two segments: commercially available Intelligent Fingerprinting Products and the development-stage Saliva Glucose Biosensor Platform. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligent Bio Solutions stock

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Intelligent Bio Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions